Urolithin A — Frequently Asked Questions

Urolithin A is a postbiotic metabolite produced by gut microbiota through the fermentation of ellagitannins found in foods like pomegranates. It is primarily studied for its ability to trigger mitophagy, the process by which cells degrade and recycle dysfunctional mitochondria.

Current evidence is emerging, with some small-scale human studies suggesting improvements in muscle endurance and strength in older adults. However, much of the foundational data regarding muscle protein synthesis and mitochondrial biogenesis comes from animal models, and large-scale, long-term human RCTs are still lacking.

While preclinical data suggests Urolithin A may mitigate age-related decline in mitochondrial function, it is premature to claim it 'reverses' aging. Research is currently focused on whether it can slow the progression of sarcopenia (age-related muscle loss) by improving mitochondrial quality control.

Clinical trials investigating muscle function have utilized doses ranging from 250mg to 1000mg daily. Because standardized dosing for long-term human health is not yet established in the literature, there is no universally agreed-upon optimal dose for mitochondrial maintenance.

Yes, the bioavailability of Urolithin A is highly dependent on the presence of specific gut bacteria capable of converting ellagitannins into the active metabolite. Individuals lacking these specific microbial strains may not derive the same systemic benefits from consuming pomegranate or berry extracts.